BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,632,089 | -21.0% | 785,164 | -4.6% | 0.05% | -13.2% |
| Q2 2023 | $37,516,291 | +8.3% | 823,448 | -3.6% | 0.05% | +1.9% |
| Q1 2023 | $34,640,795 | -21.1% | 854,063 | -0.8% | 0.05% | -24.6% |
| Q4 2022 | $43,896,587 | -4.1% | 861,224 | +1.3% | 0.07% | -10.4% |
| Q3 2022 | $45,779,000 | -16.9% | 849,971 | -0.9% | 0.08% | -11.5% |
| Q2 2022 | $55,082,000 | -16.8% | 857,575 | +0.4% | 0.09% | 0.0% |
| Q1 2022 | $66,219,000 | -14.6% | 853,998 | -5.5% | 0.09% | -4.4% |
| Q4 2021 | $77,561,000 | +10.4% | 903,556 | +3.5% | 0.09% | +1.1% |
| Q3 2021 | $70,224,000 | -1.4% | 873,108 | -1.3% | 0.09% | +1.1% |
| Q2 2021 | $71,226,000 | -10.1% | 884,795 | -5.8% | 0.09% | -15.2% |
| Q1 2021 | $79,237,000 | +1.5% | 939,489 | -3.4% | 0.10% | -3.7% |
| Q4 2020 | $78,075,000 | +1.0% | 973,024 | +1.2% | 0.11% | -12.1% |
| Q3 2020 | $77,325,000 | -5.9% | 961,516 | +0.7% | 0.12% | -14.5% |
| Q2 2020 | $82,206,000 | +10.8% | 954,775 | +4.5% | 0.14% | -9.4% |
| Q1 2020 | $74,198,000 | -3.2% | 913,883 | -0.3% | 0.16% | +23.1% |
| Q4 2019 | $76,653,000 | +7.5% | 916,680 | +12.5% | 0.13% | -6.5% |
| Q3 2019 | $71,298,000 | +7.5% | 815,112 | +0.7% | 0.14% | +6.1% |
| Q2 2019 | $66,301,000 | -2.2% | 809,542 | -2.9% | 0.13% | -5.8% |
| Q1 2019 | $67,795,000 | +21.4% | 833,784 | -1.7% | 0.14% | +9.4% |
| Q4 2018 | $55,838,000 | -15.2% | 848,351 | -0.7% | 0.13% | -0.8% |
| Q3 2018 | $65,878,000 | +4.4% | 854,554 | +0.0% | 0.13% | -2.3% |
| Q2 2018 | $63,077,000 | +15.1% | 854,237 | +1.4% | 0.13% | +12.0% |
| Q1 2018 | $54,813,000 | -2.6% | 842,752 | -3.2% | 0.12% | +0.9% |
| Q4 2017 | $56,284,000 | +3.1% | 870,728 | +0.1% | 0.12% | -4.1% |
| Q3 2017 | $54,569,000 | -4.7% | 869,628 | -8.0% | 0.12% | -0.8% |
| Q2 2017 | $57,239,000 | +8.1% | 945,464 | -7.4% | 0.12% | +14.0% |
| Q1 2017 | $52,946,000 | +12.0% | 1,020,950 | -4.2% | 0.11% | +11.5% |
| Q4 2016 | $47,264,000 | -9.2% | 1,065,950 | -2.5% | 0.10% | -10.3% |
| Q3 2016 | $52,048,000 | +6.2% | 1,093,450 | +0.8% | 0.11% | +0.9% |
| Q2 2016 | $49,030,000 | +2.2% | 1,084,250 | -7.2% | 0.11% | +3.9% |
| Q1 2016 | $47,991,000 | +23.3% | 1,168,242 | +14.5% | 0.10% | +7.4% |
| Q4 2015 | $38,924,000 | +18.0% | 1,020,295 | +1.6% | 0.10% | +10.5% |
| Q3 2015 | $32,984,000 | -52.5% | 1,004,087 | +1.0% | 0.09% | -48.8% |
| Q2 2015 | $69,511,000 | +2.1% | 994,009 | -0.0% | 0.17% | +4.3% |
| Q1 2015 | $68,102,000 | -8.1% | 994,185 | -1.7% | 0.16% | -7.5% |
| Q4 2014 | $74,117,000 | +3.1% | 1,011,285 | +1.0% | 0.17% | -2.2% |
| Q3 2014 | $71,892,000 | -3.7% | 1,001,704 | -3.0% | 0.18% | -5.3% |
| Q2 2014 | $74,655,000 | +2.9% | 1,032,567 | +4.7% | 0.19% | -2.1% |
| Q1 2014 | $72,536,000 | +6.3% | 985,817 | +0.5% | 0.19% | +3.8% |
| Q4 2013 | $68,244,000 | +6.6% | 981,217 | +0.7% | 0.18% | -2.6% |
| Q3 2013 | $64,016,000 | -2.1% | 974,517 | +3.2% | 0.19% | -10.4% |
| Q2 2013 | $65,418,000 | -5.9% | 944,393 | -1.3% | 0.21% | -9.0% |
| Q1 2013 | $69,529,000 | – | 957,167 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |